UK MHRA (Medicines and Healthcare products Regulatory Agency) orders endoscopy review amid infection fears
This article was originally published in Clinica
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has ordered an immediate assessment of all endoscope decontamination processes, amid fears of a heightened risk of infection. The review affects all staff involved not only in reprocessing, but in the "specification for purchase and in the purchasing of endoscopes".
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.